TB

This fact sheet provides an overview of the treatment of drug-susceptible tuberculosis disease in persons not infected with HIV including the recommended drug regimens, case management, and follow-up evaluations.

This fact sheet contains information about the treatment of latent TB infection (LTBI) and the prevention of active TB disease.

This report summarizes 2011 guidelines or recommendations published by multiple agencies of the U.S. Department of Health and Human Services (DHHS) for prevention and control of HIV , viral hepatitis, STDs, and TB for persons who use drugs illicitly. It also summarizes existing evidence of effectiveness for practices to support delivery of integrated prevention services.

This white paper outlines NCHHSTP’s strategic vision for program collaboration and service integration, building on and refining concepts.

Estas historias resaltan las experiencias personales de varias personas que fueron diagnosticadas y tratadas por la enfermedad de la tuberculosis, así como el trabajo de los profesionales de control de la tuberculosis.

These stories highlight the personal experiences of several people who were diagnosed and treated for TB disease, as well as the work of TB control professionals.

CureTB conecta a las personas con TB con los servicios de salud a medida que se mueven entre los Estados Unidos y otros países. Visite este sitio web para encontrar servicios y formularios de referencia para socios de salud pública que deseen presentar referencias a CureTB.

This slide set presents surveillance data based on TB case reports for 1993–2017 received by CDC.

People with HIV and latent TB infection need treatment for HIV and for latent TB infection as soon as possible to prevent them from developing TB disease. Unfortunately, some people with HIV do not know they are infected with TB. Similarly, some people with TB disease are unaware of their HIV status, although HIV status reporting for people with TB is improving. CDC recommends that anyone who has TB disease, is suspected of having TB disease, or is a contact of a TB patient be tested for HIV.

This fact sheet provides information regarding the 12-dose regimen for treating latent TB infection.